Furnish PTR, MAT Value in respect of oxygen and nitrous oxide: NPPA

Published On 2022-12-31 12:30 GMT   |   Update On 2022-12-31 12:30 GMT
Advertisement

New Delhi: Regarding the fixation of ceiling prices for scheduled formulations under revised schedule I (National List of Essential Medicines 2022) of Drug Price Control Orders 2013, the National Pharmaceutical Pricing Authority (NPPA), Ministry of Chemicals and Fertilizers, Government of India, has released an office memorandum requesting all the manufacturing and marketing companies to furnish the Price to Retailer (PTR) and Moving Annual Turnover (MAT) in value terms for the month of July 2022, in respect of in respect of Oxygen and Nitrous Oxide.

Advertisement

The list of five formulations includes: oxygen for medicinal uses containing not less than 99.0% v/v of O2, oxygen 93% for medical use, oxygen for medicinal use containing not less than 99.0% v/v of O2 in a cylinder, oxygen 93% for medicinal use in the cylinder, and nitrous oxide for medicinal use containing not less than 98% v/v of N2O.

"The information may be furnished positively within 7 days from the Issue of this O.M. in respect of Oxygen and Nitrous Oxide for taking appropriate action for fixation of ceiling prices pursuant to the issue of Revised Schedule-I of DPCO, 2013." the office memorandum added.

Scheduled formulations are any formulation that is included in the First Schedule of DPCO 2013, whether referred to by generic versions or brand names (mainly products covered under the National List of Essential Medicines are scheduled formulations). In other words, all medicines that are covered by the National List of Essential Medicines, which are notified in Schedule 1, are scheduled formulations.

"Ceiling Price" refers to a price fixed by the government for scheduled formulations in accordance with the provisions of the Drug Price Control Order of 2013. The ceiling price is the most a retailer can charge for a given product (excluding taxes, if any).

Recently, with reference to the fixation of ceiling prices for scheduled formulations under Revised Schedule I (NLEM 2022) of DPCO 2013, the NPPA has asked all the concerned manufactured and marketed companies to furnish the Price of Retailer (PTR) and Moving Annual Turnover (MAT) in value terms for the month of July 2022 in the format mentioned below.

Sl NoFormulationBrandComposition & Strenght as per the license @Price to Retailer (PTR) for July 2022 (Rs./Cubic meter)MAT * sales value as on July 2022 (Rs)Remarks( If any)
1

Oxygen ( for medicinal uses contains not less than 99.0% v/v of O2),






2

Oxygen 93%( for medical use)






3

Oxygen (For medicinal use contains not less than 99.0% v/v of O2 in a cylinder






4

Oxygen 93%( for medicinal use ) in the cylinder






5

Nitrous Oxide ( For medicinal use) contains not less than 98% v/v of N2O






Moving Annual Turnover (MAT) Sales (excluding taxes) for July 2022 means total sales during August 2021 to July 2022.
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News